中华医学会器官移植学分会, 张英才, 冯啸, 等. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J]. 器官移植, 2024, 15(5): 661-670. DOI: 10.3969/j.issn.1674-7445.2024209
引用本文: 中华医学会器官移植学分会, 张英才, 冯啸, 等. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J]. 器官移植, 2024, 15(5): 661-670. DOI: 10.3969/j.issn.1674-7445.2024209
Branch of Organ Transplantation of Chinese Medical Association, et al. Chinese practice guidelines for diagnosis and treatment of ischemic-type biliary lesion after liver transplantation[J]. ORGAN TRANSPLANTATION, 2024, 15(5): 661-670. DOI: 10.3969/j.issn.1674-7445.2024209
Citation: Branch of Organ Transplantation of Chinese Medical Association, et al. Chinese practice guidelines for diagnosis and treatment of ischemic-type biliary lesion after liver transplantation[J]. ORGAN TRANSPLANTATION, 2024, 15(5): 661-670. DOI: 10.3969/j.issn.1674-7445.2024209

肝移植术后缺血性胆道病变诊断与治疗中国实践指南

Chinese practice guidelines for diagnosis and treatment of ischemic-type biliary lesion after liver transplantation

  • 摘要: 我国肝移植历经多年的探索发展,其技术及预后已得到显著提高,术后并发症发生率也随之降低,但缺血性胆道病变仍是一个不容忽视的问题。中山大学附属第三医院于2015年制订并发表《中国大陆地区肝移植后缺血性胆道病变诊断及治疗专家共识》,现结合现阶段情况及文献报道进行更新并形成指南。本指南从缺血性胆道病变的定义、发生率、发病机制、诊断、高危因素的预防以及治疗等方面进行详细阐述,旨在为肝移植术后缺血性胆道病变的诊断与治疗提供标准化、规范化的指导,以降低再移植率和病死率,提高肝移植受者的整体生存质量。

     

    Abstract: Over the years of exploration and development, the surgical techniques and prognosis of liver transplantation in China have been significantly improved, resulting in a notable decrease in the prevalence of postoperative complications. However, ischemic-type biliary lesion remain a non-negligible issue. The Third Affiliated Hospital of Sun Yat-sen University formulated and published the "Expert Consensus on the Diagnosis and Treatment of Ischemic-Type Biliary Lesions after Liver Transplantation in Mainland China" in 2015, which has now been updated into a guideline based on current conditions and literature reports. This guideline elaborates in detail on the definition, incidence, pathogenesis, diagnosis, prevention of high-risk factors, and treatment of ischemic-type biliary lesion, aiming to provide standardized and normative guidance for the diagnosis and treatment of ischemic-type biliary lesion after liver transplantation, thereby reducing the rate of re-transplantation and fatality, and to improve the overall quality of life of liver transplant recipients.

     

/

返回文章
返回